These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12574172)

  • 1. Cardiovascular endocrinology 1: aldosterone function in diabetes mellitus: effects on cardiovascular and renal disease.
    McFarlane SI; Sowers JR
    J Clin Endocrinol Metab; 2003 Feb; 88(2):516-23. PubMed ID: 12574172
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease.
    Kalantarinia K; Okusa MD
    Curr Diab Rep; 2006 Feb; 6(1):8-16. PubMed ID: 16522275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin Academy hosts Topical Workshop session at ESH 2006.
    Renin Academy
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):126-8. PubMed ID: 17083067
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus.
    Parving HH
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):30-1. PubMed ID: 11967794
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of the renin-angiotensin-aldosterone-system on cardiovascular and renal complications in diabetes mellitus.
    Hayashi T; Takai S; Yamashita C
    Curr Vasc Pharmacol; 2010 Mar; 8(2):189-97. PubMed ID: 19485896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renin-angiotensin-aldosterone-kinin system influences on diabetic vascular disease and cardiomyopathy.
    Flack JM; Hamaty M; Staffileno BA
    Miner Electrolyte Metab; 1998; 24(6):412-22. PubMed ID: 9930381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Renin-Angiotensin system and vascular disease in diabetes.
    Deinum J; Chaturvedi N
    Semin Vasc Med; 2002 May; 2(2):149-56. PubMed ID: 16222606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes mellitus: a cardiovascular perspective.
    Varughese GI; Tomson J; Lip GY
    Int J Clin Pract; 2005 Jul; 59(7):798-816. PubMed ID: 15963208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension and diabetes: role of the renin-angiotensin system.
    Jandeleit-Dahm K; Cooper ME
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):469-90, vii. PubMed ID: 16959581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the renin-angiotensin system in the vascular disease of type II diabetes mellitus.
    Hsueh WA
    Am J Med; 1992 Apr; 92(4B):13S-19S. PubMed ID: 1580275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of renin-angiotensin-aldosterone system-based therapy in diabetes prevention and cardiovascular and renal protection.
    Abuissa H; O'Keefe J
    Diabetes Obes Metab; 2008 Dec; 10(12):1157-66. PubMed ID: 18494810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretics accelerate diabetic nephropathy in hypertensive insulin-dependent and non-insulin-dependent subjects.
    Walker WG; Hermann J; Yin DP; Murphy RP; Patz A
    Trans Assoc Am Physicians; 1987; 100():305-15. PubMed ID: 3455072
    [No Abstract]   [Full Text] [Related]  

  • 13. Renin-angiotensin-aldosterone system in diabetes mellitus.
    Christlieb AR
    Diabetes; 1976; 25(2 SUPPL):820-5. PubMed ID: 823063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diabetic nephropathy and molecular biology of the renin-angiotensin system in the diabetic kidney].
    Rodríguez Pérez JC; Barrio Castellanos R
    Med Clin (Barc); 1995 Nov; 105(18):708-15. PubMed ID: 8538254
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased aldosterone levels in a model of type 2 diabetes mellitus.
    Fredersdorf S; Endemann DH; Luchner A; Heitzmann D; Ulucan C; Birner C; Schmid P; Stoelcker B; Resch M; Muders F; Riegger GA; Weil J
    Exp Clin Endocrinol Diabetes; 2009 Jan; 117(1):15-20. PubMed ID: 18726873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone breakthrough during angiotensin II receptor blockade in hypertensive patients with diabetes mellitus.
    Yoneda T; Takeda Y; Usukura M; Oda N; Takata H; Yamamoto Y; Karashima S; Yamagishi M
    Am J Hypertens; 2007 Dec; 20(12):1329-33. PubMed ID: 18047925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications.
    Cooper ME
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):16S-20S; quiz A2-4. PubMed ID: 15539106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. End-stage renal disease in people with type 2 diabetes: systemic manifestations and exercise implications.
    Evans N; Forsyth E
    Phys Ther; 2004 May; 84(5):454-63. PubMed ID: 15113278
    [No Abstract]   [Full Text] [Related]  

  • 19. Which indexes are the most important risk factor for cardiorenal events in type 2 diabetic patients?
    Kawai T; Rakugi H
    Circ J; 2013; 77(11):2700-1. PubMed ID: 23955290
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertension and diabetes: mechanisms of elevation of arterial pressure, physiopathologic basis of therapeutic antihypertensives].
    Mogensen CE
    Journ Annu Diabetol Hotel Dieu; 1993; ():161-88. PubMed ID: 8331863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.